BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37421781)

  • 1. Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma.
    Cao J; Du X; Zhao H; Zhu C; Li C; Zhang X; Wei L; Ke X
    Biomed Pharmacother; 2023 Sep; 165():115096. PubMed ID: 37421781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone, an agonist of PPARγ, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression.
    Higuchi T; Sugisawa N; Miyake K; Oshiro H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Kline Z; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Biomed Pharmacother; 2019 Oct; 118():109356. PubMed ID: 31545293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft.
    Natarajan A; Ramachandran B; Gopisetty G; Jayavelu S; Sundersingh S; Rajkumar T
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):361-371. PubMed ID: 33015747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARγ Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model.
    Higuchi T; Yamamoto J; Sugisawa N; Tashiro Y; Nishino H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Cancer Genomics Proteomics; 2020; 17(1):35-40. PubMed ID: 31882549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
    Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
    Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLK1shRNA and doxorubicin co-loaded thermosensitive PLGA-PEG-PLGA hydrogels for osteosarcoma treatment.
    Ma H; He C; Cheng Y; Li D; Gong Y; Liu J; Tian H; Chen X
    Biomaterials; 2014 Oct; 35(30):8723-34. PubMed ID: 25017095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma.
    Yang Z; Liu J; Lu Y
    Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apatinib ameliorates doxorubicin-induced migration and cancer stemness of osteosarcoma cells by inhibiting Sox2 via STAT3 signalling.
    Tian ZC; Wang JQ; Ge H
    J Orthop Translat; 2020 May; 22():132-141. PubMed ID: 32440509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma.
    Cao J; Zhu C; Cao Z; Ke X
    Int J Biol Macromol; 2024 May; 267(Pt 2):130915. PubMed ID: 38561118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable electrospun nanofibrous platform integrating antiplatelet therapy-chemotherapy for preventing postoperative tumor recurrence and metastasis.
    Li J; Li J; Yao Y; Yong T; Bie N; Wei Z; Li X; Li S; Qin J; Jia H; Du Q; Yang X; Gan L
    Theranostics; 2022; 12(7):3503-3517. PubMed ID: 35547751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable rhein-assisted crosslinked hydrogel for efficient local osteosarcoma chemotherapy.
    Zhang L; Liu YX; Yao YT; Zhou TJ; Jiang HL; Li CJ
    Int J Pharm; 2023 Mar; 634():122637. PubMed ID: 36702387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
    Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
    Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of PLGA-based hydrogel scaffold for improving the drug maximum-tolerated dose for in situ osteosarcoma treatment.
    Yang Z; Yu S; Li D; Gong Y; Zang J; Liu J; Chen X
    Colloids Surf B Biointerfaces; 2018 Dec; 172():387-394. PubMed ID: 30193198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
    Liu Y; Raina DB; Sebastian S; Nagesh H; Isaksson H; Engellau J; Lidgren L; Tägil M
    Acta Biomater; 2021 Sep; 131():555-571. PubMed ID: 34271171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A conductive gelatin methacrylamide hydrogel for synergistic therapy of osteosarcoma and potential bone regeneration.
    Liu X; Zhang Y; Wu H; Tang J; Zhou J; Zhao J; Wang S
    Int J Biol Macromol; 2023 Feb; 228():111-122. PubMed ID: 36563819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-Microsphere/IR820 Hybrid Bifunctional Hydrogels for In Situ Osteosarcoma Chemo-
    Tan B; Wu Y; Wu Y; Shi K; Han R; Li Y; Qian Z; Liao J
    ACS Appl Mater Interfaces; 2021 Jul; 13(27):31542-31553. PubMed ID: 34191477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of adriamycin gelatin microsphere-loaded decellularized periosteum that is cytotoxic to human osteosarcoma cells.
    Chen C; Dong J; Chen H; Wang X; Mei J; Wang L; Xian CJ
    J Cell Physiol; 2019 Jul; 234(7):10771-10781. PubMed ID: 30480804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
    Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
    Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
    Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.